// App-Quantinova.ai

885 : 48-Week Complete Remission By Ethnic, Sex and Age Subgroups in Patients with Active Lupus Nephritis Treated with Voclosporin

Researchers

Presenter

  • David Wofsy

Principal Investigators

  • David A. Isenberg

  • Frdric A. Houssiau

  • Mary Anne Dooley

  • Neil Solomons

  • Simrat Randhawa

Medical Centers

  • Radiology, UCSF, San Francisco, CA

  • Centre for Rheumatology Research, UCL Division of Medicine, University College London, London, United Kingdom

  • Rheumatology, Pôle de Maladies Rhumatismales, Université catholique de Louvain, Brussels, Belgium

  • Kidney Center, UNC, Chapel Hill, NC

  • Aurinia Pharmaceuticals Inc., Victoria, BC, Canada

  • Medical Affairs, Aurinia Pharmaceuticals, Victoria, BC, Canada

Locations

  • United States

  • United Kingdom

  • Belgium

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Nephrology

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Voclosporin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved